Login to Your Account

Proposed $480M OPKO/Prolor Merger Has Law Firms Circling

By Jennifer Boggs
Managing Editor

Thursday, April 25, 2013
Within hours of Wednesday's announcement that OPKO Health Inc. and Israeli firm Prolor Biotech Inc. are seeking to merge in an all-stock transaction valued at about $480 million, several law firms said they were launching investigations into the deal on behalf of shareholders.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription